Keyword: Bedford Laboratories
The FDA will allow Xellia to begin packaging and labeling work at the former Boehringer Ingelheim plant that the Denmark company bought last year to expand its sterile manufacturing capacity. Xellia has added 90 employees and will add 80 more as it preps to start production at the facility in 2018.
The notorious ex-Boehringer Ingelheim plant in Bedford, OH, is still governed by a court-ordered consent decree ordering improvements to be made before it is serviceable again. But Denmark’s Xellia, which bought the plant last year, says the FDA is cutting it some slack on the provisions so it can ready the facility for manufacturing next year.